Works matching IS 01609289 AND DT 2012 AND VI 35 AND IP 7


Results: 19
    1
    2
    3
    4
    5
    6

    Design and Rationale of the LAPLACE-TIMI 57 Trial: A Phase II, Double-Blind, Placebo-Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 in Subjects With Hypercholesterolemia on Background Statin Therapy.

    Published in:
    Clinical Cardiology, 2012, v. 35, n. 7, p. 385, doi. 10.1002/clc.22014
    By:
    • Kohli, Payal;
    • Desai, Nihar R.;
    • Giugliano, Robert P.;
    • Kim, Jae B.;
    • Somaratne, Ransi;
    • Huang, Fannie;
    • Knusel, Beat;
    • McDonald, Shannon;
    • Abrahamsen, Timothy;
    • Wasserman, Scott M.;
    • Scott, Robert;
    • Sabatine, Marc S.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19